Clinical Trial Update: Personalized DC Vaccine for Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a personalized dendritic cell vaccine for non-small-cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Personalized dendritic cell vaccine (Autologous dendritic cell vaccine pulsed with tumor antigens)

Snippet

Sponsor: Sichuan University | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1 | Status: UNKNOWN